Dr. Hönle AG (LON:0O27)

Dr. Hönle AG Statistics

Total Valuation

Dr. Hönle AG has a market cap or net worth of GBP 43.58 million. The enterprise value is 82.57 million.

Market Cap	43.58M
Enterprise Value	82.57M

Important Dates

The last earnings date was Thursday, August 7, 2025.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	6.06M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	4.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	39.85
PS Ratio	0.53
PB Ratio	0.65
P/TBV Ratio	0.78
P/FCF Ratio	17.20
P/OCF Ratio	10.37
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.76, with an EV/FCF ratio of 32.59.

EV / Earnings	-7.09
EV / Sales	0.99
EV / EBITDA	19.76
EV / EBIT	n/a
EV / FCF	32.59

Financial Position

The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.65.

Current Ratio	1.79
Quick Ratio	0.71
Debt / Equity	0.65
Debt / EBITDA	10.52
Debt / FCF	17.18
Interest Coverage	-0.27

Financial Efficiency

Return on equity (ROE) is -15.57% and return on invested capital (ROIC) is -0.24%.

Return on Equity (ROE)	-15.57%
Return on Assets (ROA)	-0.21%
Return on Invested Capital (ROIC)	-0.24%
Return on Capital Employed (ROCE)	-0.45%
Revenue Per Employee	148,537
Profits Per Employee	-20,881
Employee Count	590
Asset Turnover	0.61
Inventory Turnover	1.15

Taxes

In the past 12 months, Dr. Hönle AG has paid 655,753 in taxes.

Income Tax	655,753
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.89% in the last 52 weeks. The beta is 1.68, so Dr. Hönle AG's price volatility has been higher than the market average.

Beta (5Y)	1.68
52-Week Price Change	-50.89%
50-Day Moving Average	9.60
200-Day Moving Average	10.82
Relative Strength Index (RSI)	34.93
Average Volume (20 Days)	78

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Dr. Hönle AG had revenue of GBP 82.88 million and -11.65 million in losses. Loss per share was -1.92.

Revenue	82.88M
Gross Profit	51.10M
Operating Income	-461,170
Pretax Income	-10.81M
Net Income	-11.65M
EBITDA	3.01M
EBIT	-461,170
Loss Per Share	-1.92

Balance Sheet

The company has 5.07 million in cash and 43.54 million in debt, giving a net cash position of -38.48 million.

Cash & Cash Equivalents	5.07M
Total Debt	43.54M
Net Cash	-38.48M
Net Cash Per Share	n/a
Equity (Book Value)	67.07M
Book Value Per Share	11.05
Working Capital	20.68M

Cash Flow

In the last 12 months, operating cash flow was 4.20 million and capital expenditures -1.67 million, giving a free cash flow of 2.53 million.

Operating Cash Flow	4.20M
Capital Expenditures	-1.67M
Free Cash Flow	2.53M
FCF Per Share	n/a

Margins

Gross margin is 61.66%, with operating and profit margins of -0.56% and -14.06%.

Gross Margin	61.66%
Operating Margin	-0.56%
Pretax Margin	-13.04%
Profit Margin	-14.06%
EBITDA Margin	3.63%
EBIT Margin	-0.56%
FCF Margin	3.06%

Dividends & Yields

Dr. Hönle AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-26.73%
FCF Yield	5.81%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Dr. Hönle AG has an Altman Z-Score of 1.67 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.67
Piotroski F-Score	4